Prostaglandins as mediators of sustained inflammation in the skin.
D000818:Animals; D001001:Anura; D003872:Dermatitis / Q000209:etiology*; D004357:Drug Synergism; D004890:Erythema / Q000473:pathology; D006632:Histamine / Q000276:immunology; D006801:Humans; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D011458:Prostaglandins E / Q000276:immunology*; D011460:Prostaglandins F / Q000276:immunology*; D051381:Rats; D012867:Skin / Q000648:ultrastructure
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D006632:Histamine; D011451:Prostaglandin-Endoperoxide Synthases